The First Reported Case of VEXAS Syndrome in Lebanon: Efficacy of Azacitidine as a Therapeutic Option-Case Report.

Saved in:
Bibliographic Details
Title: The First Reported Case of VEXAS Syndrome in Lebanon: Efficacy of Azacitidine as a Therapeutic Option-Case Report.
Authors: Issa R; Department of Internal Medicine and Clinical Immunology, Notre Dame des Secours University Hospital, Jbeil, Lebanon., Akiki B; Department of Gastroenterology and Hepatology, Notre Dame des Secours University Hospital, Jbeil, Lebanon., Georgin-Lavialle S; Department of Internal Medicine, Sorbonne University, AP-HP Tenon, Paris, France, sorbonne-universites.fr., Kosmider O; Department of Biological Hematology, Paris Cite University, AP-HP Cochin, Paris, France., Hammond D; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA, mdanderson.org., Massoud M; Department of Hematology/Oncology, Notre Dame des Secours University Hospital, Jbeil, Lebanon., Najjar V; Department of Pathology, LAU Medical Center-Rizk Hospital, Beirut, Lebanon., Dagher E; Department of Internal Medicine and Clinical Immunology, Notre Dame des Secours University Hospital, Jbeil, Lebanon.
Source: Case reports in hematology [Case Rep Hematol] 2026 May 13; Vol. 2026, pp. 3903470. Date of Electronic Publication: 2026 May 13 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Hindawi Pub. Corp Country of Publication: United States NLM ID: 101576456 Publication Model: eCollection Cited Medium: Print ISSN: 2090-6560 (Print) Linking ISSN: 20906579 NLM ISO Abbreviation: Case Rep Hematol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2090-6560
DOI:10.1155/crh/3903470